172 related articles for article (PubMed ID: 4396440)
1. [Tavegyl in the treatment of allergic diseases and neurovascular disorders of the nose].
Melik A
Schweiz Rundsch Med Prax; 1970 May; 59(18):676-8. PubMed ID: 4396440
[No Abstract] [Full Text] [Related]
2. [Experience in the clinical use of Tavegyl in nose diseases--judgment of effectiveness by cross-over method].
Sugiura S
Jibiinkoka; 1971 Nov; 43(11):931-42. PubMed ID: 4401875
[No Abstract] [Full Text] [Related]
3. [Clinical experience with Tavegyl in allergic rhinitis].
Frostad AB
Tidsskr Nor Laegeforen; 1972 Mar; 92(7):506-7. PubMed ID: 4402499
[No Abstract] [Full Text] [Related]
4. Clinical evaluation of antihistamine, HS-592, in seasonal and perennial allergic rhinitis.
Pan A
Ann Allergy; 1970 Feb; 28(2):69-72. PubMed ID: 4403482
[No Abstract] [Full Text] [Related]
5. [Allergic rhinitis treated with Tavegyl].
Ronning-Arnesen A
Tidsskr Nor Laegeforen; 1971 Nov; 91(32):2329-31. PubMed ID: 4399793
[No Abstract] [Full Text] [Related]
6. [Clinical experience with HS-592 (a new antihistaminic) for so-called allergic rhinitis].
Baba S; Oashi M; Seno Y; Maruo T
Penn Dent J (Phila); 1970 Mar; 73(2):319-22. PubMed ID: 4192065
[No Abstract] [Full Text] [Related]
7. Meclastine in hay fever.
Practitioner; 1972 Jun; 208(248):839-42. PubMed ID: 4402970
[No Abstract] [Full Text] [Related]
8. "Tavegyl" (meclastine): a pilot trial in allergic rhinitis.
Grove B
Med J Aust; 1969 Jun; 1(24):1234-6. PubMed ID: 4389674
[No Abstract] [Full Text] [Related]
9. Allergic rhinitis and its control by antihistamines: clinical trial of Tavegyl (meclastine).
Roncevich A
Curr Ther Res Clin Exp; 1969 Oct; 11(10):625-33. PubMed ID: 4390563
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of a new antihistaminic: HS-592].
von Bernath Z
Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
[No Abstract] [Full Text] [Related]
11. [Clinical trial of a new antihistaminic for allergic rhinitis].
Axelsson A
Lakartidningen; 1970 Jul; 67(27):3105-8. PubMed ID: 4393901
[No Abstract] [Full Text] [Related]
12. [Evaluation of the clinical usefulness of the antihistamine preparation HS-592 (Tavegyl-Sandoz) in treatment of allergic rhinitis and sinusitis].
Semczuk B; Klonowski S
Pol Tyg Lek; 1970 Feb; 25(8):303-5. PubMed ID: 4392044
[No Abstract] [Full Text] [Related]
13. [Clinical study of a new antihistaminic agent, Tavist].
Gyde MC
Vie Med Can Fr; 1972 Feb; 1(2):151-5. PubMed ID: 4404676
[No Abstract] [Full Text] [Related]
14. [Tavegyl in treatment of allergic skin diseases].
Kibler-Nockowska M
Wiad Lek; 1974 Apr; 27(7):645-8. PubMed ID: 4151284
[No Abstract] [Full Text] [Related]
15. [Contribution to the clinical study of HS-592 in allergic manifestations].
da Rocha JM
Hospital (Rio J); 1969 Jan; 75(1):313-5. PubMed ID: 4387990
[No Abstract] [Full Text] [Related]
16. [A new antihistaminic in the treatment of allergic diseases].
Basomba A; Oehling A
Rev Clin Esp; 1968 Jun; 109(5):417-22. PubMed ID: 4391259
[No Abstract] [Full Text] [Related]
17. Patient evaluation of clemastine fumarate and comparison with other antihistamines.
Kriz RJ
Wis Med J; 1981 Dec; 80(12):31-3. PubMed ID: 6119852
[No Abstract] [Full Text] [Related]
18. Comparative study of the efficacy and tolerance of terfenadine and clemastine in patients with seasonal allergic rhinitis.
Gastpar H; Dieterich HA
Arzneimittelforschung; 1982; 32(9a):1211-3. PubMed ID: 6129872
[TBL] [Abstract][Full Text] [Related]
19. [On the treatment of allergic and vasomotor rhinopathy with a new antihistaminic].
Fuchs T
Wien Med Wochenschr; 1969 Apr; 119(14):264-6. PubMed ID: 4388734
[No Abstract] [Full Text] [Related]
20. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
